FDA told advisers drug to be rejected
Posted: December 27, 2012 at 12:56 a.m.
Three members of an independent advisory panel say they received as much as a day’s notice in May 2010 before U.S. regulators rejected a drug from Inter-Mune Inc., now tied to an insider-trading probe of SAC Capital Advisors LP.
This story is only available from our archives.
Business, Pages 19 on 12/27/2012